These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 7696540
1. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Clarke SE, Baldwin SJ, Bloomer JC, Ayrton AD, Sozio RS, Chenery RJ. Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540 [Abstract] [Full Text] [Related]
2. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Kharasch ED, Thummel KE. Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760 [Abstract] [Full Text] [Related]
3. Evidence that cytochrome P450 2E1 is involved in the (omega-1)-hydroxylation of lauric acid in rat liver microsomes. Amet Y, Berthou F, Goasduff T, Salaun JP, Le Breton L, Menez JF. Biochem Biophys Res Commun; 1994 Sep 15; 203(2):1168-74. PubMed ID: 8093035 [Abstract] [Full Text] [Related]
4. Involvement of cytochrome P450 2E1 in the (omega-1)-hydroxylation of oleic acid in human and rat liver microsomes. Adas F, Berthou F, Picart D, Lozac'h P, Beaugé F, Amet Y. J Lipid Res; 1998 Jun 15; 39(6):1210-9. PubMed ID: 9643352 [Abstract] [Full Text] [Related]
5. Validation of the (omega-1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Amet Y, Berthou F, Baird S, Dreano Y, Bail JP, Menez JF. Biochem Pharmacol; 1995 Nov 27; 50(11):1775-82. PubMed ID: 8615855 [Abstract] [Full Text] [Related]
6. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes. Yamazaki H, Shimada T. Xenobiotica; 1999 Mar 27; 29(3):231-41. PubMed ID: 10219964 [Abstract] [Full Text] [Related]
7. Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A. Adas F, Berthou F, Salaün JP, Dréano Y, Amet Y. Toxicol Lett; 1999 Oct 29; 110(1-2):43-55. PubMed ID: 10593594 [Abstract] [Full Text] [Related]
8. Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes. Amet Y, Zerilli A, Goasduff T, Dréano Y, Berthou F. Biochem Pharmacol; 1997 Oct 15; 54(8):947-52. PubMed ID: 9354595 [Abstract] [Full Text] [Related]
9. Regiospecificity in the hydroxylation of lauric acid by rainbow trout hepatic cytochrome P450 isozymes. Miranda CL, Wang JL, Henderson MC, Williams DE, Buhler DR. Biochem Biophys Res Commun; 1990 Sep 14; 171(2):537-42. PubMed ID: 2403346 [Abstract] [Full Text] [Related]
10. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Duescher RJ, Elfarra AA. Arch Biochem Biophys; 1994 Jun 14; 311(2):342-9. PubMed ID: 8203896 [Abstract] [Full Text] [Related]
11. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Powell PK, Wolf I, Lasker JM. Arch Biochem Biophys; 1996 Nov 01; 335(1):219-26. PubMed ID: 8914854 [Abstract] [Full Text] [Related]
12. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes. Amet Y, Lucas D, Zhang-Gouillon ZQ, French SW. Alcohol Clin Exp Res; 1998 Apr 01; 22(2):455-62. PubMed ID: 9581653 [Abstract] [Full Text] [Related]
13. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Yamazaki H, Inoue K, Mimura M, Oda Y, Guengerich FP, Shimada T. Biochem Pharmacol; 1996 Feb 09; 51(3):313-9. PubMed ID: 8573198 [Abstract] [Full Text] [Related]
14. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase. Swinney DC, Webb AS, Freedman R. Biochem Pharmacol; 1991 Nov 27; 42(12):2341-9. PubMed ID: 1662512 [Abstract] [Full Text] [Related]
15. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off. Jayyosi Z, Knoble D, Muc M, Erick J, Thomas PE, Kelley M. J Pharmacol Exp Ther; 1995 Jun 27; 273(3):1156-61. PubMed ID: 7791086 [Abstract] [Full Text] [Related]
16. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO. Biochem Pharmacol; 1993 Dec 03; 46(11):1975-81. PubMed ID: 8267647 [Abstract] [Full Text] [Related]
17. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein. Chaurasia CS, Alterman MA, Lu P, Hanzlik RP. Arch Biochem Biophys; 1995 Feb 20; 317(1):161-9. PubMed ID: 7872779 [Abstract] [Full Text] [Related]
18. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, Berthou F. Chem Res Toxicol; 1993 Feb 20; 6(6):852-7. PubMed ID: 7509644 [Abstract] [Full Text] [Related]
19. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. J Clin Pharmacol; 1999 Jun 20; 39(6):567-77. PubMed ID: 10354960 [Abstract] [Full Text] [Related]
20. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T. Biochem Pharmacol; 1996 Jul 26; 52(2):301-9. PubMed ID: 8694855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]